Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
Advanced search 

 Table of Contents 
Year : 2011  |  Volume : 3  |  Issue : 3  |  Page : 160-165  

Antioxidant, cytotoxic, antitumor, and protective DNA damage metabolites from the red sea brown alga Sargassum sp

1 Department of Chemistry, Faculty of Science, King Abdul Aziz University, P. O. 80203, Jeddah 21589, Saudi Arabia
2 Department of Marine Chemsitry, Faculty of Marine Sciences, King Abdulaziz University, Jeddah 21589, P O 80207, Saudi Arabia
3 Tissue Engineering Lab., Faculty of Dentistry, Alexandria University, Alexandria, Egypt
4 Department of Pharmacognosy, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt

Date of Submission01-Feb-2011
Date of Decision06-Apr-2011
Date of Web Publication16-Sep-2011

Correspondence Address:
Seif-Eldin N Ayyad
Faculty of Sciences, King Abdulaziz University, Jeddah
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0974-8490.85000

Rights and Permissions

Background: Macroalgae can be viewed as a potential antioxidant and anti-inflammatory sources owing to their capability of producing compounds for its protection from environmental factors such as heat, pollution, stress, oxygen concentration, and UV radiations. Objective: To isolate major compounds which are mainly responsible for the pharmacological activity of brown alga under investigation, Sargassum sp. Materials and Methods: Algal material was air dried, extracted with a mixture of organic solvents, and fractionated with different adsorbents. The structures of obtained pure compounds were elucidated with different spectroscopic techniques, and two pure materials were tested for protection of DNA from damage, antioxidant, antitumor, and cytotoxicity. Results: Four pure compounds were obtained, of which fucosterol (1) and fucoxanthin (4) were tested; it was found that fucoxanthin has strong antioxidant and cytotoxicity against breast cancer (MCF-7) with IC 50 = 11.5 ΅g/ml. Conclusion: The naturally highly conjugated safe compound fucoxanthin could be used as antioxidant and as an antitumor compound.

Keywords: Antioxidant, cytotoxicity, fucoxanthin, Sargassum sp

How to cite this article:
Ayyad SEN, Ezmirly ST, Basaif SA, Alarif WM, Badria AF, Badria FA. Antioxidant, cytotoxic, antitumor, and protective DNA damage metabolites from the red sea brown alga Sargassum sp. Phcog Res 2011;3:160-5

How to cite this URL:
Ayyad SEN, Ezmirly ST, Basaif SA, Alarif WM, Badria AF, Badria FA. Antioxidant, cytotoxic, antitumor, and protective DNA damage metabolites from the red sea brown alga Sargassum sp. Phcog Res [serial online] 2011 [cited 2019 May 26];3:160-5. Available from: http://www.phcogres.com/text.asp?2011/3/3/160/85000

   Introduction Top

The genus Sargassum belongs to brown algae of class Phaeophyceae in the order Fucales. Numerous species are distributed throughout the tropical and subtropical oceans of the world, where they generally inhabit shallow water and coral reefs. However, the genus may be well known for its planktonic (free-floating) species. [1] It was clear from the literatures that more than 62 species of the genus Sargassum has been investigated, [2] and indicated its productivity with impressive diversity of natural compounds. For instances, the secondary metabolites contain different structural classes such as plastoquinones, [3],[4],[5] chromanols, [6] chromenes, [7],[8] steroids, [9] and glycerides. [10] The publications showed that, Sargassum metabolites have wide range of biological activities, which include antibiotic, anti-HIV, anticoagulant, anticonvulsant, anti-inflammatory, antineoplastic, and antitumor. [11],[12],[13],[14]

In continuation of our search program, which interested in the isolation of secondary metabolites from marine sources, especially macroalgae collected from Red Sea, [15],[16],[17] a marine macroalgae, identified as Sargassum sp., collected from El- Shuaiba lagoon 80 km south of Jeddah, was investigated. The total extract (Pet. ether: Chloroform: Methanol [1 : 1 : 1]) had been fractionated using different chromatographic techniques and afforded four metabolites; fucosterol (1), saringosterone (2), saringosterol (3), and fucoxanthin (4). 1 and 4 had been tested toward the Bleomycin-dependent DNA damage, cytotoxicity against HepG2 (human hepatocellular liver carcinoma cell line), WI 38 (Skin carcinoma cell line), Vero (cell line was initiated from the kidney of a normal adult African green monkey), MCF-7 (breast cancer cell lines), antitumor, and antioxidant using 2,2`-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS).

   Materials and Methods Top

Apparatus and material

Chromatographic material: Aluminum oxide type 60-120 mesh was used for column chromatography. Thin-layer chromatography (TLC) silica gel GF 254 was used for TLC. Preparative thin-layer chromatography (PTLC) was performed on aluminum oxide plates (20 x 20 cm) of 250-mm thickness. Electron impact mass spectra were determined at 70 eV on a Kratos MS-25 instrument. 1D and 2D NMR (Nuclear Magnetic Resonance) spectra were recorded on Bruker AVANCE III WM 600 MHz spectrometers and 13 C NMR at 150 MHz Chemical shifts are given in d (ppm) relative to TMS (Tetramethyl silane) as internal standard. The Infra Red (IR) spectra were recorded on a Perkin Elmer spectrometer model 100. The spray reagent used is 50%-sulfuric acid in methanol as spraying reagent. The chromatoplate was heated after spraying at 100 to 105°C until the spots attained maximum color intensity. The alga was described as Sargassum (Family Sargassaceae) and was collected by hand from El- Shuaiba lagoon 80 km south of Jeddah, Saudi Arabia, in the Red Sea, in June 2010.

Extraction of Sargassum sp.

The air-dried algal material (350 g) was extracted by equal volume of mixture of Pet. ether, chloroform, and methanol (2 x 6 l, 24 hours for each batch) at room temperature. The extract was concentrated under reduced pressure to obtain 10 g residue. This material was chromatographed on a column of Silica gel.

Column chromatography

Silica gel column (500 g, 80 x 2.5 cm) was used for resolution. The residue (10 g) was homogenized with small amount of silica gel (50 g) and poured on to the top of the column which was packed in Pet. ether (40: 60). The eluent were used successively (Pet. ether- Ether, Pet. ether- Ethyl acetate). Fractions were collected (50 ml); Pet. ether- Ether mixture of increasing polarity by diethyl ether and then ethyl acetate and followed by TLC using silica-gel chromatoplates, appropriate solvent system and 50% sulfuric acid in methanol as spraying reagent. If the material was not pure, preparative TLC was applied using the appropriate solvent system and the adsorbent aluminum oxide for purification.

Isolated compounds

The fraction A eluted by Pet. ether-Ether (6 : 4) was collected and rechromatographed over PTLC of silica gel using Pet. Ether-ethyl acetate (8 : 2) to give three compounds: 1 , 2, and 3 . The fraction B eluted by Pet. ether-Ethyl acetate (6 : 4) was collected and rechromatographed on Sephadex LH-20 using a mixture of MeOH-CHCl 3 (9 : 1) and then finally purified by preparative TLC of silica gel using chloroform methanol (9.5 : 0.5) to afford a pure compound 4.

Fucosterol (1), (24E0)-Stigmasta-5, 24(28)-diene-3β-ol: white solid (30 mg, 0.008% dry wt) m.p. 133-135°C. IR (cm -1 ): 3480 (OH), 1945 (C = C-H), 1640 (C = C), 1370 (gem. Di-Me); EI-MS m/z: 412 [M, C 29 H 48 O] + , 397 [M- CH 3 ] + , 379 [M-CH 3 -H 2 O] +, 314 (100) [M-C 6 H 10 O] + . 1 H NMR (CDCl 3 ) δ (ppm) 0.86- 0.88 (d, J = 6.6 Hz, 6H, Me-26 and Me-27), 0.91 (d, J = 6.6 Hz, 3H, Me-21), 0.68 (s, 3H, Me-18), 1.00 (s, 3H, Me-19), 1.59 (d, J = 6.6 Hz, 3H, Me-29), 3.53 (m, H, H-3), 5.35 (m, H, H-6), 5.11 (q, H, H-28), 2.22 (sep, J = 6.6 Hz, H, H-25). 13 C NMR (CDCl 3 ) δ (ppm) (39.75, C-1), (35.20, C-2), (71.80, C-3), (42.33, C-4), (140.74, C-5), (121.70, C-6), (36.14, C-7), (35.78, C-8), (50.10, C-9), (39.72, C-10), (28.23, C-11), (42.28, C-12), (42.30, C-13), (56.74, C-14), (31.64, C-15), (34.78, C-16), (56.72, C-17), (11.85, C-18), (19.40, C-19), (39.50, C-20), (24.32, C-21), (37.23, C-22), (31.90, C-23), (146.00, C-24), (33.90, C-25), (22.50, C-26), (22.23, C-27), (115.94, C-28), (18.90, C-29).

Saringosterone (2), 24-vinyl cholest -4-ene -3-one: a colorless oil (10 mg, 0.003% dry wt). IR (cm -1 ): 3420 (OH), 1675 (C = O), 1630 (C = C); EIMS m/z (rel. int.): 426 (12) [M, C 29 H 46 O 2 ] + , 383 (21) [M + -C 3 H 7 ], 313 (30), 271(35), 269 (100). HREIMS: m/z 426.3413 (calcd. 426.3349) C 29 H 46 O 2 ; 1 H-NMR (CDCl 3 ) δ 5.76 (dd, J = 17, 12 Hz, H, H-28), 5.73 (br s, H, H-4), 5.27 (d, J = 12 Hz, H, H-29), 5.15 (d, J = 17 Hz, H, H-29), 1.16 (s, 3H, Me-19), 0.95 (d, J = 6.5 Hz, 3H, Me-21), 0.86 (d, J = 7.0 Hz, 3H, Me-26), 0.84 (d, J = 7.0 Hz, 3H, Me-27), 0.72 (s, 3H, Me-18). 13 C-NMR δ (36.54, C-1), (34.65, C-2), (200.35, C-3), (124.43, C-4), (172.35, C-5), (33.64, C-6), (32.65, C-7), (36.32, C-8), (54.41, C-9), (39.25, C-10), (21.65, C-11), (40.22, C-12), (43.08, C-13), (56.26, C-14), (24.85, C-15), (28.86, C-16), (56.55, C-17), (12.63, C-18), (17.34, C-19), (36.84, C-20), (18.35, C-21), (32.54, C-22), (28.95, C-23), (89.76, C-24), (29.05, C-25), (19.46, C-26), (18.07, C-27), (137.78, C-28), (117.12, C-29).

Saringosterol (3), 24-vinyl cholest-5-ene-3β, 24-diol, saringosterol: colorless oil (5 mg, 0.001% dry wt.). IR (cm -1 ): 3445 (OH), 1644 (C=C); EIMS m/z (rel. int.): 428 (12) [M, C 29 H 48 O 2 ] + , 410 (6) [M + -H 2 O], 314 (40), 273(20), 271 (100), 255 (28), 228 (22), 213 (40), 145 (64). 1 H NMR (CDCl 3 ) d 5.73 (dd, J=17, 12 Hz, H, H-28), 5.34 (br s, H, H-6), 5.28 (d, J = 12 Hz, H, H-29), 5.17 (d, J = 17 Hz, H, H-29), 3.53 (m, H, H-3), 1.02 (s, 3H, Me-19), 0.97 (d, J = 6.6 Hz, 3H, Me-21), 0.88 (d, J = 6.6 Hz, 3H, Me-26], 0.86 (d, J = 6.6 Hz, 3H, Me-27), 0.67 (s, 3H, Me-18], 13 C-NMR d (37.17,C-1), (32.54, C-2), (72.43, C-3), (37.94, C-4), (141.43, C-5), (122.31, C-6), (32.35, C-7), (36.84, C-8), (50.74, C-9), (37.93, C-10), (21.75, C-11), (40.41, C-12), (42.97, C-13), (57.43, C-14), (24.95, C-15), (29.06, C-16), (56.55, C-17), (12.54, C-18), (17.32, C-19), (36.54, C-20), (18.35, C-21), (32.33, C-22), (28.95, C-23), (89.85, C-24), (29.19, C-25), (20.06, C-26), (19.53, C-27), (137.82, C-28), (117.04, C-29).

Fucoxanthin (4): red residue (60 mg, 0.017% dry wt.). IR (cm -1 ): 3439 (OH), 2361 and 2332 (sp-hybrid carbon [allenic]), 1721 and 1253 (ester), and 1654 and 1605 (polyene); HRFAB: 658.4224 (calcd. 658.4233) [C 42 H 58 O 6 ], 460(5), 391(5), 307(50), 154(100), 1 H-NMR (CDCl 3 ) d 7.15(d, J = 11.0 Hz, H, H-10), 6.75 (m, H, H-15), 6.66 (d, J = 15.0 Hz, H, H-12), 6.63 (m, H, H-15`), 6.60 (m, H, H-11`), 6.57 (m, H, H-11), 6.41 (d, J = 11.5 Hz, H, H-14), 6.35 (d, J = 15.0 Hz, H, H-12`), 6.27 (d, J = 11.5 Hz, H, H-14`), 6.13 (d, J = 11.0 Hz, H, H-10`), 6.05(br s, H, H-8`), 5.38 (m, H, H-3`), 3.81(m, H, H-3), 3.65 and 2.60 (qAB, J = 18.5 Hz, 2H, H-7), 2.33 and 1.78 (m, 2H, H-4), 2.27 and 1.51 (m, 2H, H-4`), 2.04 (s, 3H, Ac), 2.01 and 1.41(m, 2H, H-2`), 1.99 (s, 6H, H-20, H-20`), 1.95 (s, 3H, H-19), 1.81 (s, 3H, H-19`), 1.47 and 1.37 (m, 2H, H-2), 1.38 (3H, s, H-18`), 1.35 (s, 3H, H-17`), 1.22(s, 3H, H-18), 1.07 (s, 3H, H-16`), 1.03 (s, 3H, H-17), 0.96 (s, 3H, H-16). 13 C-NMR (CDCl 3 ) δ (35.18, C-1), (47.11, C-2), (64.34, C-3), (41.68, C-4), (66.19, C-5), (67.11, C-6), (40.83, C-7), (197.87, C-8), (134.54, C-9), (139.14, C-10), (123.39, C-11), (145.05, C-12), (136.67, C-13), (135.44, C-14), (132.19, C-15), (28.16, C-16), (25.06, C-17), (21.46, C-18), (11.85, C-19), (12.80, C-20), (35.79, C-1`), (45.45, C-2`), (68.03, C-3`), (45.25, C-4`), (72.71, C-5`), (117.52, C-6`), 202.36, C-7`), (103.39, C-8`), (132.19, C-9`), (128.54, C-10`), (125.71, C-11`), (138.09, C-12`), (137.11, C-13`), (132.52, C-14`), (129.44, C-15`), (31.31, C-16`), (32.14, C-17`), (29.22, C-18`), (14.04, C-19`), (12.94, C-20`), (170.45, Ac-1), (21.18, Ac-2).

Biological evaluation of the isolated compounds

DNA (Calf Thymus type1), bleomycin sulfate, butylated hydroxyanisole, thiobarbituric acid (TBA), ethylenediaminetetraacetic acid (EDTA), and ascorbic acid were obtained from sigma. 2,2'-azo-bis-(2-amidinopropane) dihydrochloride and ABTS were purchased from Wako Co., USA.

Cell viability and Bleomycin-dependent DNA damage assay in negative control (Fucoxanthin on MCF-7)

The reaction mixture contained DNA (0.5 mg/ml), bleomycin sulfate (0.05 mg/ml), MgCl 2 (5 mM), FeCl 3 (50 mM), and samples to be tested in a conc. of 0.1 mg/ml. L-ascorbic acid was used as positive control. The mixture was incubated at 370C for 1 hour. The reaction was terminated by addition of 0.05 ml EDTA (0.1 M). The color was developed by adding 0.5 ml TBA (1% w/v) and 0.5 ml HCl (25% v/v), followed by heating at 800C for 10 minutes. After centrifugation, the extent of DNA damage was measured by increase in absorbance at 532 nm. [18],[19] The viability of the cells was determined by the microscopical examination [20] using a hemocytometer and using trypan blue stain (stains only the dead cells).

Antioxidant activity screening assay 2,2`-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid method

For each of the investigated compounds, 2 ml of ABTS solution (60 μM) was added to 3 ml MnO2 solution (25 mg/ml), all prepared in 5 ml aqueous phosphate buffer solution (pH, 7; 0.1 M). The mixture was shaken, centrifuged, filtered, and the absorbance of the resulting green-blue solution (ABTS radical solution) at λ 734 nm was adjusted to approximately ca. 0.5. Then, 50μl of (2 mM) solution of the tested compound in spectroscopic grade MeOH/phosphate buffer (1: 1) was added. The absorbance was measured and the reduction in color intensity was expressed as inhibition percentage. L-ascorbic acid was used as standard antioxidant (positive control). Blank sample was run without ABTS and using MeOH/phosphate buffer (1: 1) instead of tested compounds. Negative control was run with ABTS and MeOH/phosphate buffer (1: 1) only. [21]

Cytotoxicity and antitumor assay

Samples were prepared for assay by dissolving in 50 ml of DMSO (Dimethyl Sulfoxide), and diluting aliquots into sterile culture medium at 0.4 mg/ml. These solutions were sub-diluted to 0.02 mg/ml in sterile medium and the two solutions were used as stocks to test samples at 100, 50, 20, 10, 5, 2, and 1 mg/ml in triplicate in the wells of microtiter plates. The compounds were assayed in triplicate on monolayers grown in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) calf serum (HyClone Laboratories, Ogden, UT), 60 mg/ml Penicillin G, and 100 mg/ml streptomycin sulfate maintained at 37°C in a humidified atmosphere containing about 15% (v/v) CO 2 in air. All medium components were obtained from Sigma Chemical Co., St. Louis, MO, unless otherwise indicated. Cell stocks were maintained at 34°C in culture flasks filled with medium supplemented with 1% (v/v) calf serum. Subcultures of cells for screening were grown in the wells of microtiter trays (Falcon Microtest III 96-wells trays, Becton Dickinson Labware, Lincolin Park, NJ) by suspending cells in medium following trypsin-EDTA treatment, counting the suspension with a hemocytometer, diluting in medium containing 10% calf serum to 2 x 104 cells per 200 ml culture, aliquoting into each well of a tray, and culturing until confluent. Microtiter trays with confluent monolayer cultures of cells were inverted, the medium shaken out, and replaced with serial dilutions of sterile compounds in triplicate in 100 l medium followed by titered virus in 100 ml medium containing 10% (v/v) calf serum in each well. In each tray, the last row of wells was reserved for controls that were not treated with compounds. Trays were cultured for 96 hours. Trays were inverted onto a paper towel pad, the remaining cells rinsed carefully with medium, and fixed with 3.7% (v/v) formaldehyde in saline for at least 20 minutes. The fixed cells were rinsed with water, and examined visually. The cytotoxic activity is identified as confluent, relatively unaltered monolayers of stained cells treated with the investigated compounds. Cytotoxicity was estimated as the concentration that caused approximately 50% loss of the monolayer. 5-fluorouracil was used as a positive control. [22]

   Results and Discussion Top

Compound 1 showed in its EI MS a molecular ion at m/z 412, (Liebermann-burchard reaction gave the typical slow reacting green color of a Δ5 sterol) which [23] together with 13 C NMR data suggested a molecular formula of C 29 H 48 O. The loss of part of the side chain (C 7 H 14 ) is characteristic of sterols [23] with a Δ24(28) . 1H NMR spectroscopic data were typical of sterols, in which a signal at δ 0.88 (6H, d, J= 6.6 Hz) attributable to the two methyls of an isopropyl group, a signal at δ 0.91 (3H, d, J= 6.6 Hz) and two signals at δ 1.00 (3H, s) and at δ 0.68 (3H, s) assigned to two methyl groups attached to two quaternary carbons are assigned to C-26, C-27, C-21, C-19 and C-18, respectively. In addition, a doublet at δ 1.59 ppm (J= 6.6 Hz) for the proton at C-29 (δc 18.70), a quartet δ 5.18 ppm (J = 6.6 Hz) at C-28 proton (δc 115.54), a multiplet at δ 5.35 for C-6 proton (δc 121.70), and a multiplet at 3.53 for C-3 proton (δc 71.80) were observed. 13 C NMR of compound 1 indicated 29 carbons, of which two double bonds and a secondary alcohol (cf exp.) were present. The DEPT spectra showed that compound 1 contains six methyl, ten methylene, nine methane, and four quaternary carbons. The stereochemistry at the side chain double bond can be explained by observing the 1HNMR spectra at the C-25 proton which resonates at δ 2.32 ppm (δc 36.50) in case of (E) isomer (Frost, ward, 1968). The position of the ethylidene group was proved from HMQC, HMBC correlations, and COSY experiment. These data are in agreement with literature [24] which can allow us to assign compound 1 as fucosterol [Figure 1].
Figure 1: Structure of compounds 1-4

Click here to view

Compound 2 showed in its EI MS a molecular ion at m/z 426, which together with 13 C-NMR and HREI MS suggested a molecular formula of C 29 H 46 O 2 (m/z 426.3413; calcd. 426.3349). The double doublet at δ 5.75 (J = 18, 13 Hz), doublet at 5.29 (J = 13 Hz), and doublet at 5.17 (J = 18 Hz) in the 1H-NMR and signals at δc 137.79 and 117.10 in the 13 C NMR were attributable to terminal vinyl protons, three methyl doublets at 0.96, 0.87, 0.85 in the 1 H-NMR spectrum. These data, together with the presence of a fragment at m/z 271 in the mass spectrum due to the loss of the side-chain C 10 H 19 O, suggest a stigmastane skeleton with unsaturation at C-28. The IR spectrum showed strong bands at 3420 and 1675 cm -1 . The above data, together with the presence of signals at δc 200.38, 172.38, 124.42, and 89.75 in the 13C NMR spectrum and a signal at δ 5.74 in the 1 H NMR spectrum, suggested the presence of α,β -unsaturated carbonyl group and a tertiary hydroxyl function in the molecule. As the compound contains two double bonds and two oxygen atoms, one as carbonyl and the second as tertiary hydroxyl, also has seven degrees of unsaturation revealed by mass spectrometry, it must be a tetracyclic product. The structure of known compound 2 [Figure 1] was established by comparison of its data (cf exp.) with literature. [25]

Compound 3 , its structure was established by comparing their physical and spectral data (cf exp.) with those in the literature [25],[26] as 24-vinyl cholest -5-ene -3β, 24-diol.

Compound 4 was isolated as a bright orange solid and the IR showed the presence of the hydroxyl

(3439 cm -1 ), sp-hybrid carbon (allenic) (2361, 2332 cm -1 ), ester (1721, 1253 cm -1 ), and polyene (1654, 1605 cm -1 ) groups. Its molecular formula was deduced as C 42 H 58 O 6 based on HRFAB-MS analysis [M + ], m/z: 658.4224 (Calcd. for C 42 H 58 O 6 , 658. 4233), and NMR spectroscopic data (cf exp.). The 1 H and 13 C NMR spectra of active compound revealed signals assignable to polyene having acetyl, conjugated ketone, two quaternary geminal dimethyls, two quaternary geminal methyls of oxygen, four olefinic methyls, and allene functionalities. The physicochemical features outlined above suggested that the active compound was a carotenoid in which one of the hydroxyl groups was acetylated. This suggestion was further supported by the UV spectrum [448 (e560,000), 248 (24,000)]. From detailed comparison of the data for the active compound with those of fucoxanthin [Figure 1], the active compound was in agreement with an authentic fucoxanthin in all aspects. [27],[28],[29]

The data obtained from [Table 1] indicate that fucoxanthin (4) have some protective activity to DNA by certain mechanism . The isolated compounds were screened for their antitumor activity against MCF-7. The viability of the cells used in control experiments exceeded 95%; compound 4 proved to have cytotoxic activity sustained for 48 hours after adding the compound to MCF-7, as shown in [Table 1]. Compounds 1 and 4 were tested for antioxidant activity, where fucoxanthin (4) exhibited the highest antioxidant activity by 72% inhibition [Table 2]. On the other hand, compound 1 exhibited a weak to moderate activity.
Table 1: Cell viability and bleomycin-dependent DNA damage assay of fucoxanthin (4)

Click here to view
Table 2: Antioxidant activity of tested compounds by ABTS method

Click here to view

Compounds 1 and 4 displayed significant antioxidant and anticancer activities [Table 3] against HepG2 (human hepatocellular liver carcinoma cell line), WI 38 (Skin carcinoma cell line), Vero (cell line was initiated from the kidney of a normal adult African green monkey), and MCF-7 (breast cancer cell lines). Fucoxanthin reduced the viability of MCF-7 cells with IC50 (mg/ml) = 11.5.
Table 3: Cytotoxicity of tested compounds on different cancer cell lines

Click here to view

   Acknowledgment Top

The authors would like to acknowledge SABIC, the Saudi Arabian Company for Basic Industries, for the financial support of this work (SP-11-2) through the collaboration with the Deanship of Scientific Research (DSR) at King Abdul-Aziz University.

   References Top

1.Blunt JW, Munro MH. Marin Literature Database. Department of Chemistry, University of Canterbury: Christchurch, New Zealand; 2007.  Back to cited text no. 1
2.Blunt JW, Copp BR, Hu WP, Munro MH, Northcote PT, Prinsep MR. Marine natural products. Nat Prod Rep. 2008; 25:35-94.  Back to cited text no. 2
3.Segawa M, Shirahama H. New Plastoquinones from the Brown Alga Sargassum sagamianum var. yezoense. Chemical Letters 1987; 1:1365-66.  Back to cited text no. 3
4.Mori J, Iwashima M, Wakasugi H, Saito H, Matsunaga T, Ogasawara M, et al. New plastoquinones isolated from the brown alga, Sargassum micracanthum. Chem Pharm Bull (Tokyo) 2005;53:1159-63.  Back to cited text no. 4
5.Ishitsuka M, Kusumi T, Nomura Y, Konno T, Kakisawa H. New geranylgeranylbenzoquinone derivatives from Sargassum tortile. Chemical Letters 1979;8:1269-72.  Back to cited text no. 5
6.Kato T, Kumanireng AS, Ichinose I, Kitahara Y, Kakinuma Y, Kato Y. Structure and synthesis of the active component from a marine alga, Sargassum tortile, which induces the settling of swimming larvae of Coryne uchidai. Chemical Letters 1975;4:335-8.  Back to cited text no. 6
7.Jang KH, Lee BH, Choi BW, Lee HS, Shin J. Chromenes from the brown alga Sargassum siliquastrum. J Nat Prod 2005;68:716-23.  Back to cited text no. 7
8.Kikuchi T, Mori Y, Yokoi T, Nakazawa S, Kuroda H, Masada Y, et al. Structure of sargatriol, a new isoprenoid chromenol from a marine alga, Sargassum tortile. Chem Pharm Bull (Tokyo) 1975;23:690-2.  Back to cited text no. 8
9.Tang H, Yi Y, Yao X, Zhou D, Lu T, Jiang Y. Studies on bioactive steroid constituents from Sargassum carpophyllum. Chin Pham J 2002;37:262-5.  Back to cited text no. 9
10.Tang H, Yi Y, Yao X, Zhang S, Zou Z, Li L. Glycerides from marine brown algae Sargassum carpophyllum. Chinese Journal of Marine Drugs 2002; 21:5-9.  Back to cited text no. 10
11.Ayyad S-EN, Abdel-Halim OB, Shier WT, Hoye TR. Cytotoxic hydroazulene diterpenes from brown alga Cystoseira myrica. Z Naturforsch C 2003;58:33-8.  Back to cited text no. 11
12.Lincolon RA, Strupinski K, Walker JM. Bioactive compounds from algae. Life Chem Rep 1991;8:97-183.  Back to cited text no. 12
13.Ayyad S-EN, Slama MO, Mokhtar AH, Anter AF. Cytotoxic bicyclic diterpene from the brown alga Sargassum crispum. Boll Chim Farm 2001;140:155-9.  Back to cited text no. 13
14.Banais B, Francisco C, Gonzalez E, Fenical W. Diterpenoid metabolites from the marine alga Cystoseira elegans. Tetrahedron 1983;39:629-38.  Back to cited text no. 14
15.Alarif WM, Ayyad S-EN, Al-lihaibi SS. Acyclic Diterpenoid from the Red Alga Gracilaria Foliifera. Rev Latinoamer Quím 2010;38:52-8.  Back to cited text no. 15
16.Alarif, WM, Abou-Elnaga Z Sh, Ayyad S-EN, Al-lihaibi SS. Insecticidal Metabolites from the Green Alga Caulerpa racemosa. CLEAN - Soil, Air and Water 2010;38:548-57.  Back to cited text no. 16
17.Ayyad S-EN, Makki MS, Al-kayal NS, Basaif SA, El-Foty KO, Asiri AM, et al. Cytotoxic and Protective DNA Damage of Three New Diterpenoids from the Brown Alga Dictoyota dichotoma. Eur J Med Chem 2011;46:175-82.  Back to cited text no. 17
18.Gutterdge J, Rowley D, Halliwell B. Superoxide dependent formation of hydroxyl radicals in the presence of iron salts. Detection of free ion in biological systems using bleomycin-dependent degradation of DNA. Biochem J 1981;199:263-5.  Back to cited text no. 18
19.Abdel-Wahab BF, El-Ahl AA, Badria FA. Synthesis of new 2-naphthyl ethers and their protective activities against DNA damage induced by bleomycin-iron. Chem Pharm Bull (Tokyo) 2009;57:1348-51.  Back to cited text no. 19
20.Badria F, Ameen M, Akl MR. Evaluation of Cytotoxic Compounds from Calligonum comosum L. growing in Egypt. Z 2007;62:656-60.  Back to cited text no. 20
21.El-Gazzar AB, Youssef MM, Abu-Hashem AA, Badria FA. Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as anti-oxidant, anti-inflammatory and analgesic activities. Eur J Med Chem 2009;44;609-24.  Back to cited text no. 21
22.El-Subbagh HI, Abu-Zaid SM, Mahran MA, Badria FA, Al-obaid AM. Synthesis and biological evaluation of certain alpha, beta-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents. J Med Chem 2000;43:2915-21.  Back to cited text no. 22
23.Gibbons GF, Goad LJ, Goodwin TW. The identification of 28- isofucosterol in the marine green algae Enteromorpha intestinalis and Ulva lactuca. Phytochemistry 1968;7:983-8.  Back to cited text no. 23
24.Goad JL, Akihisa T. Analysis of Sterols. 1 st ed. London: Blackie Academic and Professional; 1977. p. 382-3.  Back to cited text no. 24
25.Ayyad S-EN, Sowellim SZ, el-Hosini MS, Abo-Atia A. The structural determination of a new steroidal metabolite from the brown alga Sargassum asperifolium. Z Naturforsch C 2003;58:333-6.  Back to cited text no. 25
26.Tsuda K, Hayatsu R, Kashida Y, Akagi S. Steroid studies IV. Studies on the constitution of sargasterol. J Am Chem Soc 1958;80:921-5.  Back to cited text no. 26
27.Haugan JA, Englert G, Glinz E, Liaaen-Jensen S. Algal carotenoids. 48. Structural assignments of geometrical isomers of fucoxanthin. Acta Chem Scand 1992;46:389-95.  Back to cited text no. 27
28.Yan X, ChudaY, Suzuki M, Nagata T. Fucoxanthin as the major antioxidant in Hizikia fusiformis, a common edible seaweed. Biosci Biotechnol Biochem 1999;63:605-7.  Back to cited text no. 28
29.Ayyad S-EN, Diab M. NMR Application of Mosher's Method: The absolute configurations of fucoxanthin from Turbinaria triquatra. Alex J Pharm Sci 2002;16:27-30.  Back to cited text no. 29


  [Figure 1]

  [Table 1], [Table 2], [Table 3]

This article has been cited by
1 Phylogenetic Tree Analysis of the Cold-Hot Nature of Traditional Chinese Marine Medicine for Possible Anticancer Activity
Xianjun Fu,Xuxia Song,Xuebo Li,Kah Keng Wong,Jiaoyang Li,Fengcong Zhang,Changyun Wang,Zhenguo Wang
Evidence-Based Complementary and Alternative Medicine. 2017; 2017: 1
[Pubmed] | [DOI]
2 Health benefit of fucosterol from marine algae: a review
Qudeer Ahmed Abdul,Ran Joo Choi,Hyun Ah Jung,Jae Sue Choi
Journal of the Science of Food and Agriculture. 2016; 96(6): 1856
[Pubmed] | [DOI]
3 Can macroalgae provide promising anti-tumoral compounds? A closer look atCystoseira tamariscifoliaas a source for antioxidant and anti-hepatocarcinoma compounds
Catarina Vizetto-Duarte,Luísa Custódio,Gerardo Acosta,João H.G. Lago,Thiago R. Morais,Carolina Bruno de Sousa,Katkam N. Gangadhar,Maria João Rodrigues,Hugo Pereira,Raquel T. Lima,M. Helena Vasconcelos,Luísa Barreira,Amélia P. Rauter,Fernando Albericio,João Varela
PeerJ. 2016; 4: e1704
[Pubmed] | [DOI]
4 Seasonal Composition of Lipids, Fatty Acids Pigments in the Brown Alga <i>Sargassum pallidum</i>: The Potential for Health
Natalia Gerasimenko,Stepan Logvinov
Open Journal of Marine Science. 2016; 06(04): 498
[Pubmed] | [DOI]
5 Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment
Luc Martin
Marine Drugs. 2015; 13(8): 4784
[Pubmed] | [DOI]
6 Synthesis, antiviral, cytotoxicity and antitumor evaluations of A4type of porphyrin derivatives
Ahmed A. Fadda,Rasha E. El-Mekawy,Ahmed I. El-Shafei
Journal of Porphyrins and Phthalocyanines. 2015; 19(06): 753
[Pubmed] | [DOI]
7 Fucosterol protects cobalt chloride induced inflammation by the inhibition of hypoxia-inducible factor through PI3K/Akt pathway
Zhengwang Sun,Mohamed Antar Aziz Mohamed,Sang Yong Park,Tae Hoo Yi
International Immunopharmacology. 2015; 29(2): 642
[Pubmed] | [DOI]
8 The major bioactive components of seaweeds and their mosquitocidal potential
Ke-Xin Yu,Ibrahim Jantan,Rohani Ahmad,Ching-Lee Wong
Parasitology Research. 2014;
[Pubmed] | [DOI]
9 Potential of antioxidant extracts produced by aqueous processing of renewable resources for the formulation of cosmetics
Elena M. Balboa,Maria Luisa Soto,Daniele R. Nogueira,Noelia González-López,Enma Conde,Andrés Moure,María Pilar Vinardell,Montserrat Mitjans,Herminia Domínguez
Industrial Crops and Products. 2014; 58: 104
[Pubmed] | [DOI]
10 Differential growth inhibition of cancer cell lines and antioxidant activity of extracts of red, brown, and green marine algae
Kavitha Murugan,Vidhya V. Iyer
In Vitro Cellular & Developmental Biology - Animal. 2013; 49(5): 324
[Pubmed] | [DOI]
11 Synthesis and antitumor activity of new pyrido[2,3-d]pyrimidine derivatives
Magdy M. Gineinah,Magda N. A. Nasr,Sahar M. I. Badr,Walaa M. El-Husseiny
Medicinal Chemistry Research. 2013; 22(8): 3943
[Pubmed] | [DOI]
12 In vitro antioxidant properties of crude extracts and compounds from brown algae
Elena M. Balboa,Enma Conde,Andres Moure,Elena Falqué,Herminia Domínguez
Food Chemistry. 2013; 138(2-3): 1764
[Pubmed] | [DOI]
13 Anti-Cancer Mechanism and Possibility of Nano-Suspension Formulation for a Marine Algae Product Fucoxanthin
Srinivasan Muthuirulappan,Steffi Pulikodan Francis
Asian Pacific Journal of Cancer Prevention. 2013; 14(4): 2213
[Pubmed] | [DOI]
14 comparative analysis of antioxidant potential of sargassum sp and lyengaria sp
butt, g. and hussain, e. and rehman, a.
pakistan journal of medical and health sciences. 2013; 7(4): 1128-1129
15 utility of quaternary ammonium salts in synthesis of some novel cyanine dyes as potential antibacterial and antitumor agents
fadda, a.a. and el-mekawy, r.e.
dyes and pigments. 2013; 99(2): 512-519
16 Utility of quaternary ammonium salts in synthesis of some novel cyanine dyes as potential antibacterial and antitumor agents
A.A. Fadda,Rasha E. El-Mekawy
Dyes and Pigments. 2013; 99(2): 512
[Pubmed] | [DOI]
17 Fucoxantin: A Treasure from the Sea
Nicolantonio D’Orazio,Eugenio Gemello,Maria Gammone,Massimo de Girolamo,Cristiana Ficoneri,Graziano Riccioni
Marine Drugs. 2012; 10(12): 604
[Pubmed] | [DOI]
18 Fucoxantin: A treasure from the sea
DæOrazio, N., Gemello, E., Gammone, M.A., De Girolamo, M., Ficoneri, C., Riccioni, G.
Marine Drugs. 2012; 10(3): 604-616
19 Glycerol derivatives and steroid constituents from the soft coral rumphella aggregata (gorgoniidae) of saudi red sea water
Alarif, W.M.
Journal of King Abdulaziz University, Marine Science. 2012; 23(2): 57-67


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
    Materials and Me...
    Results and Disc...
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded33    
    Comments [Add]    
    Cited by others 19    

Recommend this journal